Latest Breaking News On - Apellis pharmaceutical - Page 1 : vimarsana.com

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) to Post Q2 2024 Earnings of ($0 42) Per Share, Wedbush Forecasts

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) to Post Q2 2024 Earnings of ($0 42) Per Share, Wedbush Forecasts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Pascal deschateletsTimothy eugene sullivanSecurities exchange commissionInstitutional trading of apellis pharmaceuticalsApellis pharmaceuticals stock downCovestor ltdNews ratings for apellis pharmaceuticals dailyChina universal asset management coApellis pharmaceuticalsFinancial wealth managmentFirst horizon advisors incApellis pharmaceuticals incFree reportApellis pharmaceuticalGet free reportPharmaceuticals stock down

Wedbush Weighs in on Apellis Pharmaceuticals, Inc s FY2025 Earnings (NASDAQ:APLS)

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush dropped their FY2025 EPS estimates for Apellis Pharmaceuticals in a report released on Wednesday, April 17th. Wedbush analyst L. Chico now expects that the company will earn $2.23 per share for the year, down from their prior estimate of $2.24. Wedbush currently has […]

United statesAdamj townsendRobertw bairdJames george chopasSecurities exchange commissionHedge funds weigh in on apellis pharmaceuticalsApellis pharmaceuticals incApellis pharmaceuticals stock performanceCharles schwab investment management incNews ratings for apellis pharmaceuticals dailyGoldman sachs groupProfund advisorsApellis pharmaceuticalsAmerican investors coWynnefield capital incJefferies financial group

Hedge Funds Watching Drug Makers | Law Street Media

Hedge Funds Watching Drug Makers | Law Street Media
lawstreetmedia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawstreetmedia.com Daily Mail and Mail on Sunday newspapers.

United statesGeorgetown universityDistrict of columbiaBruxelles capitaleCosta ricaMashonaland eastWhite houseNew yorkSan diegoBob doleHogan lovellsEugene dozortsevJohna jenkinsAstellas pharmaRandye millerCatalent indiana

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) Is Expected To Breakeven In The Near Future

We feel now is a pretty good time to analyse Apellis Pharmaceuticals, Inc.'s ( NASDAQ:APLS ) business as it appears the.

Apellis pharmaceuticalsManagement teamApellis pharmaceuticalSimply wallHigh performing stocks

Apellis Pharmaceuticals (NASDAQ:APLS) PT Raised to $60 00 at Wedbush

Apellis Pharmaceuticals (NASDAQ:APLS) PT Raised to $60 00 at Wedbush
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Pascal deschateletsCaroline baumalRaymond jamesNews ratings for apellis pharmaceuticals dailyApellis pharmaceuticals stockCim investment management incNeuberger berman groupJpmorgan chase coFirst horizon advisors incSecurities exchange commissionAnalyst recommendations for apellis pharmaceuticalsApellis pharmaceuticals incInstitutional investors weigh in on apellis pharmaceuticalsApellis pharmaceuticals company profileAdvisor group holdings incApellis pharmaceuticals